Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

0.2272
-0.0115-4.82%
Post-market: 0.23000.0028+1.23%19:59 EDT
Volume:197.63K
Turnover:45.13K
Market Cap:10.12M
PE:-0.29
High:0.2450
Open:0.2450
Low:0.2178
Close:0.2387
Loading ...

HCW Biologics to Implement 1-for-40 Reverse Stock Split

MT Newswires Live
·
02 Apr

HCW Biologics Announces Reverse Stock Split Approval

TIPRANKS
·
02 Apr

HCW Biologics approves 1-for-40 reverse stock split

TIPRANKS
·
02 Apr

BRIEF-HCW Biologics Announces 1-For-40 Reverse Stock Split

Reuters
·
02 Apr

HCW Biologics Announces 1-for-40 Reverse Stock Split

THOMSON REUTERS
·
02 Apr

HCW Biologics Announces 1-for-40 Reverse Stock Split

GlobeNewswire
·
02 Apr

HCW Biologics Q4 EPS $(0.08) Up From $(0.30) YoY, Sales $394.80K Down From $1.32M YoY

Benzinga
·
29 Mar

Press Release: HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

Dow Jones
·
29 Mar

HCW Biologics granted extension by Nasdaq to regain listing compliance

TIPRANKS
·
06 Mar

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance With Continued Listing Requirements

THOMSON REUTERS
·
06 Mar

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

GlobeNewswire
·
06 Mar

HCW Biologics: Buy Rating Affirmed Amid IND Clearance and Strategic Advancements

TIPRANKS
·
05 Feb

Top Midday Gainers

MT Newswires Live
·
04 Feb

Dow Falls 150 Points; ISM Manufacturing PMI Rises In January

Benzinga
·
04 Feb

S&P 500 Down Over 1%; Tyson Foods Posts Upbeat Results

Benzinga
·
03 Feb

HCW Biologics Advances with FDA Clearance for Trial

TIPRANKS
·
03 Feb

BUZZ-HCW Biologics rises as US FDA approves trial for hair loss treatment

Reuters
·
03 Feb

HCW Biologics Says FDA Approves Trial of HCW9302 to Treat Alopecia Areata; Shares Rise Pre-Bell

MT Newswires Live
·
03 Feb

HCW Biologics receives clearance of IND from FDA for HCW9302

TIPRANKS
·
03 Feb

HCW Biologics Inc - HCW9302 Shows Efficacy in Treating Autoimmune Diseases

THOMSON REUTERS
·
03 Feb